‘WHO As Fragile As It Is Indispensable’ – Report Probes Geneva Global Health Hub’s Response To COVID Crisis 12/03/2021 Geneva Solutions One year after the World Health Organization (WHO) declared the coronavirus outbreak a pandemic on 11 March 2020, a new report by the Foundation for Geneva has traced the success and the failures of the WHO and other international Geneva organisations in their response – as well as the implications for the future of multilateralism. […] Continue reading -> As European Medicines Agency Approves One-Shot Johnson & Johnson COVID Vaccine – US Has Surplus & Africa A Dearth of Doses 11/03/2021 Elaine Ruth Fletcher & Raisa Santos With the European Union Medicines Agency (EMA) approval Thursday of Johnson and Johnson’s one-shot COVID-19 vaccine, it now remains to be seen which countries and regions will be the first in line for distribution of the one-jab vaccine. Along with its comparatively low-cost, and ease of storage, the one-shot vaccine could be particularly important to […] Continue reading -> Kenyan Health Officials Say They Hope To Ratify African Medicines Agency Treaty Soon – Improving Regulatory Process 11/03/2021 Geoffrey Kamadi NAIROBI – Kenya is one of the leading African countries yet to ratify the African Medicines Agency Treaty (AMA) – but a senior official in the Ministry of Health has said that the move should come soon. According to Susan Mochache, the country’s Principal Secretary in the Ministries of Health (MoH), Kenya has already undergone […] Continue reading -> Why An African Medicines Agency? Now More Than Ever! 11/03/2021 Safeeyah Kharsany “The future generations are not going to excuse this,” pleaded Kawaldip Sehmi, CEO of the International Alliance of Patients’ Organizations (IAPO). “They will be looking at us and will say, ‘What the hell were they doing procrastinating on their neighbors during a pandemic?” Sehmi was one of seven speakers from across Africa who convened at […] Continue reading -> Aspirin May Help Protect Against COVID-19 Infection & Serious Disease: New Peer-Reviewed Study Suggests 10/03/2021 Editorial team A study of people taking regular, low doses of aspirin found that the aspirin users were 29% less likely than others to test positive for COVID-19, as well as being less prone to serious disease and its “long COVID” after-effects. The new peer-reviewed study, published in The FEBS Journal of the Federation of European Biochemical […] Continue reading -> Violence Against Women Is “Unequivocally Pervasive”, Reveals Largest WHO Study Ever 09/03/2021 Svĕt Lustig Vijay Almost one in three women experience physical and/or sexual violence across the course of their lifetimes. And over the past 12 months, more than one in ten women suffered from physical and/or sexual intimate partner violence, according to a new WHO-led report on gender-based violence, published just a day after International Women’s Day. Gender-based violence […] Continue reading -> COVID-19 Vaccine Summit: Largest Manufacturing Scaleup World Has Ever Seen Presents Big Challenges – No Easy Fixes 09/03/2021 Kerry Cullinan & Elaine Ruth Fletcher A two-day summit of the world’s top pharma and public health sector players to address COVID-19 vaccine supply chain and manufacturing bottlenecks ended on Tuesday with agreement that large vaccine manufacturing scale up potential exists – even in 2021 – but the route is complex and there are no easy fixes. And most immediately, there […] Continue reading -> More Investments Needed To Fight Covid-19 And Further Disease Outbreaks 09/03/2021 Chandre Prince African governments, the private sector, and development partners need to invest more in health and health systems to intensify the fight against the COVID-19 pandemic and any future disease outbreaks, according to health experts speaking at the African Health Agenda International Conference (AHAIC) on Tuesday. The experts agreed that a comprehensive, multi-sectoral approach is needed […] Continue reading -> Chinese Sinovac Vaccine Shows Reduced Efficacy Against SARS-CoV2 Variant Identified In Brazil – But AstraZeneca’s Holds Up Well – Early Data 08/03/2021 Madeleine Hoecklin The Chinese-developed “CoronaVac” vaccine against COVID-19 vaccine triggers a sixfold reduction in neutralizing antibody response against the P.1 variant first identified in Brazil, according to a pre-print study published last week, while the Oxford/AstraZeneca vaccine is likely effective against the variant of concern. These findings come as hospitals in northern Brazil are increasingly overwhelmed and […] Continue reading -> Patents ‘Not’ The Main Barrier To Equitable Vaccine Rollout – Two Leading Vaccine Scientists & Pharma Execs At WHO Event 08/03/2021 Elaine Ruth Fletcher The structural barriers to a faster and more equitable COVID-19 vaccine roll-out go far beyond the issue of patents, declared two of the world’s leading vaccine researchers and pharma execs at a WHO event on Monday evening. Sarah Gilbert, developer of the Oxford/AstraZeneca vaccine and Özlem Türeci, chief medical officer of BioNTech, the developer of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
As European Medicines Agency Approves One-Shot Johnson & Johnson COVID Vaccine – US Has Surplus & Africa A Dearth of Doses 11/03/2021 Elaine Ruth Fletcher & Raisa Santos With the European Union Medicines Agency (EMA) approval Thursday of Johnson and Johnson’s one-shot COVID-19 vaccine, it now remains to be seen which countries and regions will be the first in line for distribution of the one-jab vaccine. Along with its comparatively low-cost, and ease of storage, the one-shot vaccine could be particularly important to […] Continue reading -> Kenyan Health Officials Say They Hope To Ratify African Medicines Agency Treaty Soon – Improving Regulatory Process 11/03/2021 Geoffrey Kamadi NAIROBI – Kenya is one of the leading African countries yet to ratify the African Medicines Agency Treaty (AMA) – but a senior official in the Ministry of Health has said that the move should come soon. According to Susan Mochache, the country’s Principal Secretary in the Ministries of Health (MoH), Kenya has already undergone […] Continue reading -> Why An African Medicines Agency? Now More Than Ever! 11/03/2021 Safeeyah Kharsany “The future generations are not going to excuse this,” pleaded Kawaldip Sehmi, CEO of the International Alliance of Patients’ Organizations (IAPO). “They will be looking at us and will say, ‘What the hell were they doing procrastinating on their neighbors during a pandemic?” Sehmi was one of seven speakers from across Africa who convened at […] Continue reading -> Aspirin May Help Protect Against COVID-19 Infection & Serious Disease: New Peer-Reviewed Study Suggests 10/03/2021 Editorial team A study of people taking regular, low doses of aspirin found that the aspirin users were 29% less likely than others to test positive for COVID-19, as well as being less prone to serious disease and its “long COVID” after-effects. The new peer-reviewed study, published in The FEBS Journal of the Federation of European Biochemical […] Continue reading -> Violence Against Women Is “Unequivocally Pervasive”, Reveals Largest WHO Study Ever 09/03/2021 Svĕt Lustig Vijay Almost one in three women experience physical and/or sexual violence across the course of their lifetimes. And over the past 12 months, more than one in ten women suffered from physical and/or sexual intimate partner violence, according to a new WHO-led report on gender-based violence, published just a day after International Women’s Day. Gender-based violence […] Continue reading -> COVID-19 Vaccine Summit: Largest Manufacturing Scaleup World Has Ever Seen Presents Big Challenges – No Easy Fixes 09/03/2021 Kerry Cullinan & Elaine Ruth Fletcher A two-day summit of the world’s top pharma and public health sector players to address COVID-19 vaccine supply chain and manufacturing bottlenecks ended on Tuesday with agreement that large vaccine manufacturing scale up potential exists – even in 2021 – but the route is complex and there are no easy fixes. And most immediately, there […] Continue reading -> More Investments Needed To Fight Covid-19 And Further Disease Outbreaks 09/03/2021 Chandre Prince African governments, the private sector, and development partners need to invest more in health and health systems to intensify the fight against the COVID-19 pandemic and any future disease outbreaks, according to health experts speaking at the African Health Agenda International Conference (AHAIC) on Tuesday. The experts agreed that a comprehensive, multi-sectoral approach is needed […] Continue reading -> Chinese Sinovac Vaccine Shows Reduced Efficacy Against SARS-CoV2 Variant Identified In Brazil – But AstraZeneca’s Holds Up Well – Early Data 08/03/2021 Madeleine Hoecklin The Chinese-developed “CoronaVac” vaccine against COVID-19 vaccine triggers a sixfold reduction in neutralizing antibody response against the P.1 variant first identified in Brazil, according to a pre-print study published last week, while the Oxford/AstraZeneca vaccine is likely effective against the variant of concern. These findings come as hospitals in northern Brazil are increasingly overwhelmed and […] Continue reading -> Patents ‘Not’ The Main Barrier To Equitable Vaccine Rollout – Two Leading Vaccine Scientists & Pharma Execs At WHO Event 08/03/2021 Elaine Ruth Fletcher The structural barriers to a faster and more equitable COVID-19 vaccine roll-out go far beyond the issue of patents, declared two of the world’s leading vaccine researchers and pharma execs at a WHO event on Monday evening. Sarah Gilbert, developer of the Oxford/AstraZeneca vaccine and Özlem Türeci, chief medical officer of BioNTech, the developer of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Kenyan Health Officials Say They Hope To Ratify African Medicines Agency Treaty Soon – Improving Regulatory Process 11/03/2021 Geoffrey Kamadi NAIROBI – Kenya is one of the leading African countries yet to ratify the African Medicines Agency Treaty (AMA) – but a senior official in the Ministry of Health has said that the move should come soon. According to Susan Mochache, the country’s Principal Secretary in the Ministries of Health (MoH), Kenya has already undergone […] Continue reading -> Why An African Medicines Agency? Now More Than Ever! 11/03/2021 Safeeyah Kharsany “The future generations are not going to excuse this,” pleaded Kawaldip Sehmi, CEO of the International Alliance of Patients’ Organizations (IAPO). “They will be looking at us and will say, ‘What the hell were they doing procrastinating on their neighbors during a pandemic?” Sehmi was one of seven speakers from across Africa who convened at […] Continue reading -> Aspirin May Help Protect Against COVID-19 Infection & Serious Disease: New Peer-Reviewed Study Suggests 10/03/2021 Editorial team A study of people taking regular, low doses of aspirin found that the aspirin users were 29% less likely than others to test positive for COVID-19, as well as being less prone to serious disease and its “long COVID” after-effects. The new peer-reviewed study, published in The FEBS Journal of the Federation of European Biochemical […] Continue reading -> Violence Against Women Is “Unequivocally Pervasive”, Reveals Largest WHO Study Ever 09/03/2021 Svĕt Lustig Vijay Almost one in three women experience physical and/or sexual violence across the course of their lifetimes. And over the past 12 months, more than one in ten women suffered from physical and/or sexual intimate partner violence, according to a new WHO-led report on gender-based violence, published just a day after International Women’s Day. Gender-based violence […] Continue reading -> COVID-19 Vaccine Summit: Largest Manufacturing Scaleup World Has Ever Seen Presents Big Challenges – No Easy Fixes 09/03/2021 Kerry Cullinan & Elaine Ruth Fletcher A two-day summit of the world’s top pharma and public health sector players to address COVID-19 vaccine supply chain and manufacturing bottlenecks ended on Tuesday with agreement that large vaccine manufacturing scale up potential exists – even in 2021 – but the route is complex and there are no easy fixes. And most immediately, there […] Continue reading -> More Investments Needed To Fight Covid-19 And Further Disease Outbreaks 09/03/2021 Chandre Prince African governments, the private sector, and development partners need to invest more in health and health systems to intensify the fight against the COVID-19 pandemic and any future disease outbreaks, according to health experts speaking at the African Health Agenda International Conference (AHAIC) on Tuesday. The experts agreed that a comprehensive, multi-sectoral approach is needed […] Continue reading -> Chinese Sinovac Vaccine Shows Reduced Efficacy Against SARS-CoV2 Variant Identified In Brazil – But AstraZeneca’s Holds Up Well – Early Data 08/03/2021 Madeleine Hoecklin The Chinese-developed “CoronaVac” vaccine against COVID-19 vaccine triggers a sixfold reduction in neutralizing antibody response against the P.1 variant first identified in Brazil, according to a pre-print study published last week, while the Oxford/AstraZeneca vaccine is likely effective against the variant of concern. These findings come as hospitals in northern Brazil are increasingly overwhelmed and […] Continue reading -> Patents ‘Not’ The Main Barrier To Equitable Vaccine Rollout – Two Leading Vaccine Scientists & Pharma Execs At WHO Event 08/03/2021 Elaine Ruth Fletcher The structural barriers to a faster and more equitable COVID-19 vaccine roll-out go far beyond the issue of patents, declared two of the world’s leading vaccine researchers and pharma execs at a WHO event on Monday evening. Sarah Gilbert, developer of the Oxford/AstraZeneca vaccine and Özlem Türeci, chief medical officer of BioNTech, the developer of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Why An African Medicines Agency? Now More Than Ever! 11/03/2021 Safeeyah Kharsany “The future generations are not going to excuse this,” pleaded Kawaldip Sehmi, CEO of the International Alliance of Patients’ Organizations (IAPO). “They will be looking at us and will say, ‘What the hell were they doing procrastinating on their neighbors during a pandemic?” Sehmi was one of seven speakers from across Africa who convened at […] Continue reading -> Aspirin May Help Protect Against COVID-19 Infection & Serious Disease: New Peer-Reviewed Study Suggests 10/03/2021 Editorial team A study of people taking regular, low doses of aspirin found that the aspirin users were 29% less likely than others to test positive for COVID-19, as well as being less prone to serious disease and its “long COVID” after-effects. The new peer-reviewed study, published in The FEBS Journal of the Federation of European Biochemical […] Continue reading -> Violence Against Women Is “Unequivocally Pervasive”, Reveals Largest WHO Study Ever 09/03/2021 Svĕt Lustig Vijay Almost one in three women experience physical and/or sexual violence across the course of their lifetimes. And over the past 12 months, more than one in ten women suffered from physical and/or sexual intimate partner violence, according to a new WHO-led report on gender-based violence, published just a day after International Women’s Day. Gender-based violence […] Continue reading -> COVID-19 Vaccine Summit: Largest Manufacturing Scaleup World Has Ever Seen Presents Big Challenges – No Easy Fixes 09/03/2021 Kerry Cullinan & Elaine Ruth Fletcher A two-day summit of the world’s top pharma and public health sector players to address COVID-19 vaccine supply chain and manufacturing bottlenecks ended on Tuesday with agreement that large vaccine manufacturing scale up potential exists – even in 2021 – but the route is complex and there are no easy fixes. And most immediately, there […] Continue reading -> More Investments Needed To Fight Covid-19 And Further Disease Outbreaks 09/03/2021 Chandre Prince African governments, the private sector, and development partners need to invest more in health and health systems to intensify the fight against the COVID-19 pandemic and any future disease outbreaks, according to health experts speaking at the African Health Agenda International Conference (AHAIC) on Tuesday. The experts agreed that a comprehensive, multi-sectoral approach is needed […] Continue reading -> Chinese Sinovac Vaccine Shows Reduced Efficacy Against SARS-CoV2 Variant Identified In Brazil – But AstraZeneca’s Holds Up Well – Early Data 08/03/2021 Madeleine Hoecklin The Chinese-developed “CoronaVac” vaccine against COVID-19 vaccine triggers a sixfold reduction in neutralizing antibody response against the P.1 variant first identified in Brazil, according to a pre-print study published last week, while the Oxford/AstraZeneca vaccine is likely effective against the variant of concern. These findings come as hospitals in northern Brazil are increasingly overwhelmed and […] Continue reading -> Patents ‘Not’ The Main Barrier To Equitable Vaccine Rollout – Two Leading Vaccine Scientists & Pharma Execs At WHO Event 08/03/2021 Elaine Ruth Fletcher The structural barriers to a faster and more equitable COVID-19 vaccine roll-out go far beyond the issue of patents, declared two of the world’s leading vaccine researchers and pharma execs at a WHO event on Monday evening. Sarah Gilbert, developer of the Oxford/AstraZeneca vaccine and Özlem Türeci, chief medical officer of BioNTech, the developer of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Aspirin May Help Protect Against COVID-19 Infection & Serious Disease: New Peer-Reviewed Study Suggests 10/03/2021 Editorial team A study of people taking regular, low doses of aspirin found that the aspirin users were 29% less likely than others to test positive for COVID-19, as well as being less prone to serious disease and its “long COVID” after-effects. The new peer-reviewed study, published in The FEBS Journal of the Federation of European Biochemical […] Continue reading -> Violence Against Women Is “Unequivocally Pervasive”, Reveals Largest WHO Study Ever 09/03/2021 Svĕt Lustig Vijay Almost one in three women experience physical and/or sexual violence across the course of their lifetimes. And over the past 12 months, more than one in ten women suffered from physical and/or sexual intimate partner violence, according to a new WHO-led report on gender-based violence, published just a day after International Women’s Day. Gender-based violence […] Continue reading -> COVID-19 Vaccine Summit: Largest Manufacturing Scaleup World Has Ever Seen Presents Big Challenges – No Easy Fixes 09/03/2021 Kerry Cullinan & Elaine Ruth Fletcher A two-day summit of the world’s top pharma and public health sector players to address COVID-19 vaccine supply chain and manufacturing bottlenecks ended on Tuesday with agreement that large vaccine manufacturing scale up potential exists – even in 2021 – but the route is complex and there are no easy fixes. And most immediately, there […] Continue reading -> More Investments Needed To Fight Covid-19 And Further Disease Outbreaks 09/03/2021 Chandre Prince African governments, the private sector, and development partners need to invest more in health and health systems to intensify the fight against the COVID-19 pandemic and any future disease outbreaks, according to health experts speaking at the African Health Agenda International Conference (AHAIC) on Tuesday. The experts agreed that a comprehensive, multi-sectoral approach is needed […] Continue reading -> Chinese Sinovac Vaccine Shows Reduced Efficacy Against SARS-CoV2 Variant Identified In Brazil – But AstraZeneca’s Holds Up Well – Early Data 08/03/2021 Madeleine Hoecklin The Chinese-developed “CoronaVac” vaccine against COVID-19 vaccine triggers a sixfold reduction in neutralizing antibody response against the P.1 variant first identified in Brazil, according to a pre-print study published last week, while the Oxford/AstraZeneca vaccine is likely effective against the variant of concern. These findings come as hospitals in northern Brazil are increasingly overwhelmed and […] Continue reading -> Patents ‘Not’ The Main Barrier To Equitable Vaccine Rollout – Two Leading Vaccine Scientists & Pharma Execs At WHO Event 08/03/2021 Elaine Ruth Fletcher The structural barriers to a faster and more equitable COVID-19 vaccine roll-out go far beyond the issue of patents, declared two of the world’s leading vaccine researchers and pharma execs at a WHO event on Monday evening. Sarah Gilbert, developer of the Oxford/AstraZeneca vaccine and Özlem Türeci, chief medical officer of BioNTech, the developer of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Violence Against Women Is “Unequivocally Pervasive”, Reveals Largest WHO Study Ever 09/03/2021 Svĕt Lustig Vijay Almost one in three women experience physical and/or sexual violence across the course of their lifetimes. And over the past 12 months, more than one in ten women suffered from physical and/or sexual intimate partner violence, according to a new WHO-led report on gender-based violence, published just a day after International Women’s Day. Gender-based violence […] Continue reading -> COVID-19 Vaccine Summit: Largest Manufacturing Scaleup World Has Ever Seen Presents Big Challenges – No Easy Fixes 09/03/2021 Kerry Cullinan & Elaine Ruth Fletcher A two-day summit of the world’s top pharma and public health sector players to address COVID-19 vaccine supply chain and manufacturing bottlenecks ended on Tuesday with agreement that large vaccine manufacturing scale up potential exists – even in 2021 – but the route is complex and there are no easy fixes. And most immediately, there […] Continue reading -> More Investments Needed To Fight Covid-19 And Further Disease Outbreaks 09/03/2021 Chandre Prince African governments, the private sector, and development partners need to invest more in health and health systems to intensify the fight against the COVID-19 pandemic and any future disease outbreaks, according to health experts speaking at the African Health Agenda International Conference (AHAIC) on Tuesday. The experts agreed that a comprehensive, multi-sectoral approach is needed […] Continue reading -> Chinese Sinovac Vaccine Shows Reduced Efficacy Against SARS-CoV2 Variant Identified In Brazil – But AstraZeneca’s Holds Up Well – Early Data 08/03/2021 Madeleine Hoecklin The Chinese-developed “CoronaVac” vaccine against COVID-19 vaccine triggers a sixfold reduction in neutralizing antibody response against the P.1 variant first identified in Brazil, according to a pre-print study published last week, while the Oxford/AstraZeneca vaccine is likely effective against the variant of concern. These findings come as hospitals in northern Brazil are increasingly overwhelmed and […] Continue reading -> Patents ‘Not’ The Main Barrier To Equitable Vaccine Rollout – Two Leading Vaccine Scientists & Pharma Execs At WHO Event 08/03/2021 Elaine Ruth Fletcher The structural barriers to a faster and more equitable COVID-19 vaccine roll-out go far beyond the issue of patents, declared two of the world’s leading vaccine researchers and pharma execs at a WHO event on Monday evening. Sarah Gilbert, developer of the Oxford/AstraZeneca vaccine and Özlem Türeci, chief medical officer of BioNTech, the developer of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
COVID-19 Vaccine Summit: Largest Manufacturing Scaleup World Has Ever Seen Presents Big Challenges – No Easy Fixes 09/03/2021 Kerry Cullinan & Elaine Ruth Fletcher A two-day summit of the world’s top pharma and public health sector players to address COVID-19 vaccine supply chain and manufacturing bottlenecks ended on Tuesday with agreement that large vaccine manufacturing scale up potential exists – even in 2021 – but the route is complex and there are no easy fixes. And most immediately, there […] Continue reading -> More Investments Needed To Fight Covid-19 And Further Disease Outbreaks 09/03/2021 Chandre Prince African governments, the private sector, and development partners need to invest more in health and health systems to intensify the fight against the COVID-19 pandemic and any future disease outbreaks, according to health experts speaking at the African Health Agenda International Conference (AHAIC) on Tuesday. The experts agreed that a comprehensive, multi-sectoral approach is needed […] Continue reading -> Chinese Sinovac Vaccine Shows Reduced Efficacy Against SARS-CoV2 Variant Identified In Brazil – But AstraZeneca’s Holds Up Well – Early Data 08/03/2021 Madeleine Hoecklin The Chinese-developed “CoronaVac” vaccine against COVID-19 vaccine triggers a sixfold reduction in neutralizing antibody response against the P.1 variant first identified in Brazil, according to a pre-print study published last week, while the Oxford/AstraZeneca vaccine is likely effective against the variant of concern. These findings come as hospitals in northern Brazil are increasingly overwhelmed and […] Continue reading -> Patents ‘Not’ The Main Barrier To Equitable Vaccine Rollout – Two Leading Vaccine Scientists & Pharma Execs At WHO Event 08/03/2021 Elaine Ruth Fletcher The structural barriers to a faster and more equitable COVID-19 vaccine roll-out go far beyond the issue of patents, declared two of the world’s leading vaccine researchers and pharma execs at a WHO event on Monday evening. Sarah Gilbert, developer of the Oxford/AstraZeneca vaccine and Özlem Türeci, chief medical officer of BioNTech, the developer of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
More Investments Needed To Fight Covid-19 And Further Disease Outbreaks 09/03/2021 Chandre Prince African governments, the private sector, and development partners need to invest more in health and health systems to intensify the fight against the COVID-19 pandemic and any future disease outbreaks, according to health experts speaking at the African Health Agenda International Conference (AHAIC) on Tuesday. The experts agreed that a comprehensive, multi-sectoral approach is needed […] Continue reading -> Chinese Sinovac Vaccine Shows Reduced Efficacy Against SARS-CoV2 Variant Identified In Brazil – But AstraZeneca’s Holds Up Well – Early Data 08/03/2021 Madeleine Hoecklin The Chinese-developed “CoronaVac” vaccine against COVID-19 vaccine triggers a sixfold reduction in neutralizing antibody response against the P.1 variant first identified in Brazil, according to a pre-print study published last week, while the Oxford/AstraZeneca vaccine is likely effective against the variant of concern. These findings come as hospitals in northern Brazil are increasingly overwhelmed and […] Continue reading -> Patents ‘Not’ The Main Barrier To Equitable Vaccine Rollout – Two Leading Vaccine Scientists & Pharma Execs At WHO Event 08/03/2021 Elaine Ruth Fletcher The structural barriers to a faster and more equitable COVID-19 vaccine roll-out go far beyond the issue of patents, declared two of the world’s leading vaccine researchers and pharma execs at a WHO event on Monday evening. Sarah Gilbert, developer of the Oxford/AstraZeneca vaccine and Özlem Türeci, chief medical officer of BioNTech, the developer of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Chinese Sinovac Vaccine Shows Reduced Efficacy Against SARS-CoV2 Variant Identified In Brazil – But AstraZeneca’s Holds Up Well – Early Data 08/03/2021 Madeleine Hoecklin The Chinese-developed “CoronaVac” vaccine against COVID-19 vaccine triggers a sixfold reduction in neutralizing antibody response against the P.1 variant first identified in Brazil, according to a pre-print study published last week, while the Oxford/AstraZeneca vaccine is likely effective against the variant of concern. These findings come as hospitals in northern Brazil are increasingly overwhelmed and […] Continue reading -> Patents ‘Not’ The Main Barrier To Equitable Vaccine Rollout – Two Leading Vaccine Scientists & Pharma Execs At WHO Event 08/03/2021 Elaine Ruth Fletcher The structural barriers to a faster and more equitable COVID-19 vaccine roll-out go far beyond the issue of patents, declared two of the world’s leading vaccine researchers and pharma execs at a WHO event on Monday evening. Sarah Gilbert, developer of the Oxford/AstraZeneca vaccine and Özlem Türeci, chief medical officer of BioNTech, the developer of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Patents ‘Not’ The Main Barrier To Equitable Vaccine Rollout – Two Leading Vaccine Scientists & Pharma Execs At WHO Event 08/03/2021 Elaine Ruth Fletcher The structural barriers to a faster and more equitable COVID-19 vaccine roll-out go far beyond the issue of patents, declared two of the world’s leading vaccine researchers and pharma execs at a WHO event on Monday evening. Sarah Gilbert, developer of the Oxford/AstraZeneca vaccine and Özlem Türeci, chief medical officer of BioNTech, the developer of […] Continue reading -> Posts navigation Older postsNewer posts